Loading...

COLTENE Holding AG

0QP7.LLSE
Healthcare
Medical - Equipment & Services
£50.50
£-0.60(-1.17%)

COLTENE Holding AG (0QP7.L) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for COLTENE Holding AG (0QP7.L), covering cash flow, earnings, and balance sheets.

Revenue Growth
3.06%
3.06%
Operating Income Growth
36.89%
36.89%
Net Income Growth
71.31%
71.31%
Operating Cash Flow Growth
9.96%
9.96%
Operating Margin
10.73%
10.73%
Gross Margin
47.26%
47.26%
Net Profit Margin
8.18%
8.18%
ROE
19.60%
19.60%
ROIC
23.53%
23.53%

COLTENE Holding AG (0QP7.L) Income Statement & Financial Overview

Review COLTENE Holding AG 0QP7.L income statement with detailed quarterly and annual figures.

MetricQ4 2024Q2 2024Q4 2023Q2 2023
Revenue$122.66M$127.50M$111.30M$131.43M
Cost of Revenue$89.41M$42.52M$87.30M$95.77M
Gross Profit$33.25M$84.98M$24.001M$35.67M
Gross Profit Ratio$0.27$0.67$0.22$0.27
R&D Expenses$0.00$0.00$10.24M$0.00
SG&A Expenses$19.38M$47.08M$18.81M$21.25M
Operating Expenses$19.38M$72.002M$18.82M$21.24M
Total Costs & Expenses-$108.79M$114.53M$106.12M$117.005M
Interest Income$0.00$543000.00$0.00$1.16M
Interest Expense$903000.00$0.00$2.33M$1.16M
Depreciation & Amortization$3.44M$3.46M$3.40M$3.45M
EBITDA$17.30M$16.98M$8.58M$17.87M
EBITDA Ratio$0.14$0.13$0.08$0.14
Operating Income$13.86M$12.98M$5.18M$14.43M
Operating Income Ratio$0.11$0.10$0.05$0.11
Other Income/Expenses (Net)-$903000.00$543000.00-$2.33M-$1.16M
Income Before Tax$12.96M$13.52M$2.86M$13.26M
Income Before Tax Ratio$0.11$0.11$0.03$0.10
Income Tax Expense$2.91M$3.10M$931000.00$3.24M
Net Income$10.05M$10.42M$1.93M$10.02M
Net Income Ratio$0.08$0.08$0.02$0.08
EPS$1.68$1.74$0.32$1.68
Diluted EPS$1.68$1.74$0.32$1.68
Weighted Avg Shares Outstanding$5.98M$5.99M$5.98M$5.98M
Weighted Avg Shares Outstanding (Diluted)$5.98M$5.99M$5.98M$5.98M

Over the last four quarters, COLTENE Holding AG's revenue moved from $131.43M in Q2 2023 to $122.66M in Q4 2024. Operating income in Q4 2024 was $13.86M, with a strong operating margin of 11%. Despite fluctuations in R&D and SG&A expenses, EBITDA for COLTENE Holding AG remained robust at $17.30M, reflecting operational efficiency. Net income dropped to $10.05M, with an EPS of $1.68. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;